Asthma Clinical Trial
Official title:
The Use of a Heat and Moisture Exchange Mask to Reduce Exercise Induced Bronchoconstriction Severity and Improve the Airway Health of Individuals With Asthma
The overall aim of this study is to determine if face masks that can warm and humidify air can improve overall asthma control and markers of airway health during exercise in cold dry environments. We will investigate the potential protective benefits of the face masks against exercise induced asthma during 1) a "one-off" bout of exercise in a cold dry environment and 2) over the course of a four week period, exercising three times per week in a cold dry environment.
Physical activity is recognised as a trigger for individuals with asthma, however regular
physical activity is considered to be important in the overall management of the condition.
There is clear evidence that demonstrates if individuals with asthma engage with regular
physical activity they will improve their physical fitness and breathing control, whilst at
the same time experiencing reductions in asthma severity, symptoms, and medication use. In
addition undertaking regular exercise reduces the risk of developing other diseases such as
heart disease or type 2 diabetes. Despite the clear health benefits of engaging in regular
physical activity there is evidence that some people with asthma avoid physical activity due
to shortness of breath, worsening asthma symptoms during physical activity or fear of
experiencing such symptoms.
Physical activity in cold dry environments exacerbates symptoms for many individuals with
asthma resulting in greater avoidance of physical activity during the winter months. The
increased risk of asthma from exercising in cold environments has led to Asthma UK advising
susceptible individuals to avoid exercise outside in cold environments
(http://www.asthma.org.uk/advice-exercise). This places obvious constraints and limitations
on individuals with asthma for whom the aim of optimum treatment is to allow them to follow a
"normal" lifestyle. Indeed, exposure to cold air on exertion is relevant to a significant
proportion of individuals with asthma who engage with outdoor physical activity as part of
their daily routine; e.g. cycle-commuting to work, outdoor construction workers.
A mask that is able to warm and humidify the air during exercise may provide a solution for
asthmatic individuals susceptible to cold dry environments. There are a limited number of
small studies that provide tentative evidence suggesting masks which warm and humidify air
can protect against reductions in lung function during and following physical activity.
However, it is unknown whether the use of these masks provides protection against the
mechanisms that drive asthmatic symptoms. It is also unclear whether using the masks over a
prolonged period of time significantly reduces asthma severity, inhaler use, or presence of
symptoms.
The overall aim of this study is to determine if face masks that can warm and humidify air
can improve overall asthma control and markers of airway health during exercise in cold dry
environments. We will investigate the potential protective benefits of the face masks against
exercise induced asthma during 1) a "one-off" bout of exercise in a cold dry environment and
2) over the course of a four week period, exercising three times per week in a cold dry
environme
;
Status | Clinical Trial | Phase | |
---|---|---|---|
Terminated |
NCT04410523 -
Study of Efficacy and Safety of CSJ117 in Patients With Severe Uncontrolled Asthma
|
Phase 2 | |
Completed |
NCT04624425 -
Additional Effects of Segmental Breathing In Asthma
|
N/A | |
Active, not recruiting |
NCT03927820 -
A Pharmacist-Led Intervention to Increase Inhaler Access and Reduce Hospital Readmissions (PILLAR)
|
N/A | |
Completed |
NCT04617015 -
Defining and Treating Depression-related Asthma
|
Early Phase 1 | |
Recruiting |
NCT03694158 -
Investigating Dupilumab's Effect in Asthma by Genotype
|
Phase 4 | |
Terminated |
NCT04946318 -
Study of Safety of CSJ117 in Participants With Moderate to Severe Uncontrolled Asthma
|
Phase 2 | |
Completed |
NCT04450108 -
Vivatmo Pro™ for Fractional Exhaled Nitric Oxide (FeNO) Monitoring in U.S. Asthmatic Patients
|
N/A | |
Completed |
NCT03086460 -
A Dose Ranging Study With CHF 1531 in Subjects With Asthma (FLASH)
|
Phase 2 | |
Completed |
NCT01160224 -
Oral GW766944 (Oral CCR3 Antagonist)
|
Phase 2 | |
Completed |
NCT03186209 -
Efficacy and Safety Study of Benralizumab in Patients With Uncontrolled Asthma on Medium to High Dose Inhaled Corticosteroid Plus LABA (MIRACLE)
|
Phase 3 | |
Completed |
NCT02502734 -
Effect of Inhaled Fluticasone Furoate on Short-term Growth in Paediatric Subjects With Asthma
|
Phase 3 | |
Completed |
NCT01715844 -
L-Citrulline Supplementation Pilot Study for Overweight Late Onset Asthmatics
|
Phase 1 | |
Terminated |
NCT04993443 -
First-In-Human Study to Evaluate the Safety, Tolerability, Immunogenicity, and Pharmacokinetics of LQ036
|
Phase 1 | |
Completed |
NCT02787863 -
Clinical and Immunological Efficiency of Bacterial Vaccines at Adult Patients With Bronchopulmonary Pathology
|
Phase 4 | |
Recruiting |
NCT06033833 -
Long-term Safety and Efficacy Evaluation of Subcutaneous Amlitelimab in Adult Participants With Moderate-to-severe Asthma Who Completed Treatment Period of Previous Amlitelimab Asthma Clinical Study
|
Phase 2 | |
Completed |
NCT03257995 -
Pharmacodynamics, Safety, Tolerability, and Pharmacokinetics of Two Orally Inhaled Indacaterol Salts in Adult Subjects With Asthma.
|
Phase 2 | |
Completed |
NCT02212483 -
Clinical Effectiveness and Economical Impact of Medical Indoor Environment Counselors Visiting Homes of Asthma Patients
|
N/A | |
Recruiting |
NCT04872309 -
MUlti-nuclear MR Imaging Investigation of Respiratory Disease-associated CHanges in Lung Physiology
|
||
Withdrawn |
NCT01468805 -
Childhood Asthma Reduction Study
|
N/A | |
Recruiting |
NCT05145894 -
Differentiation of Asthma/COPD Exacerbation and Stable State Using Automated Lung Sound Analysis With LungPass Device
|